Literature DB >> 4405273

The alpha and beta adrenergic responses to epinephrine in the rabbit eye.

M E Langham, A Simjee, S Josephs.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4405273     DOI: 10.1016/0014-4835(73)90192-9

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


× No keyword cloud information.
  8 in total

1.  Ocular hypotensive effect of atenolol (Tenormin, I.C.I.). A new beta-adrenergic blocker.

Authors:  M J Elliot; P M Cullen; C I Phillips
Journal:  Br J Ophthalmol       Date:  1975-06       Impact factor: 4.638

2.  The pupillary, the intraocular pressure and the vasomotor responses to noradrenaline in rabbits.

Authors:  M E Langham; K Palewicz
Journal:  J Physiol       Date:  1977-05       Impact factor: 5.182

3.  Adrenaline-thymoxamine interaction and intraocular pressure.

Authors:  A Rushton
Journal:  Br J Clin Pharmacol       Date:  1980-04       Impact factor: 4.335

4.  [The effect of timolol and dipivalyl-epinephrine in the treatment of the elevated intraocular pressure (author's transl)].

Authors:  M Ober; A Scharrer
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1980

5.  [The effect of repeated adrenaline application on intraocular pressure and pupil in the rabbit (author's transl)].

Authors:  G K Krieglstein; M E Langham
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1975-09-05

6.  Effects of adrenergic drugs on aqueous cAMP and cGMP and intraocular pressure.

Authors:  J M Rowland; D E Potter
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1979

7.  The effect of hypotensive drugs on the intraocular pressure after waterloading in rabbits.

Authors:  O P van Bijsterveld; A C van Loenen; M ten Ham
Journal:  Doc Ophthalmol       Date:  1981-12-16       Impact factor: 2.379

8.  Interaction of atenolol and adrenaline with respect to intraocular pressure.

Authors:  A Rushton
Journal:  Br J Clin Pharmacol       Date:  1979-06       Impact factor: 4.335

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.